Given the poor prognostic role of HAVCR1 in various tumor types, we focused on the role of HAVCR1 in Liver hepatocellular carcinoma (p < 0.01) and Pancreatic adenocarcinoma (p < 0.001). This evidence concerns the gene HAVCR1 and pancreatic adenocarcinoma.